Pharmacy

Fazer A Publicacao Dos Artigos Do Draft 4 1

Pfizer Issues Voluntary Nationwide Recall for Lots of Quinapril HCI Due to N-Nitroso-Quinapril Content

Pfizer voluntarily recalled 5 lots of quinapril HCI (Accupril) tablets distributed to the patient level as a result of the presence of the N-nitroso-quinapril nitrosamine, observed in recent testing over the acceptable daily intake (ADI) level. Pfizer recalls Accupril According to Pfizer press release, nitrosamines are common in water and numerous foods, such as cured […]

Pfizer Issues Voluntary Nationwide Recall for Lots of Quinapril HCI Due to N-Nitroso-Quinapril Content Read More »

Design Sem Nome 75 2

Drug-Like Molecules Indicate New Strategies for Cancer Cells Therapy

Drug-like molecules hold great promise for developing new strategies in cancer cell therapy. These molecules can specifically target cancer cells and disrupt their growth and proliferation, while sparing normal cells. Ten years ago, genome sequencing unveiled a considerable surprise: almost 50 percent of human cancers are related to mutations known as epigenetic regulators that govern

Drug-Like Molecules Indicate New Strategies for Cancer Cells Therapy Read More »

Fazer A Publicacao Dos Artigos Do Draft 5 3

The Promising Brand-new Antimalarial Compound Found

A study from the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University has led to the promising discovery of a new antimalarial compound. The discovery unlocks the possibility of developing new drugs targeting malaria, one of the deadliest infectious diseases on Earth. Gerry Wright, a biochemistry and biomedical sciences professor, co-led the

The Promising Brand-new Antimalarial Compound Found Read More »

Design Sem Nome 1 1

Lung Fibrosis Reversed in Mice Using Existing FDA-Approved Drug

Lung fibrosis is a lung condition involving too much scarring that affects people’s breathing and currently can not be treated. But now, scientists at the College of Alabama have discovered a way to turn around the problem in mice, utilizing a drug currently available for various other usages. In patients with idiopathic lung fibrosis (IPF),

Lung Fibrosis Reversed in Mice Using Existing FDA-Approved Drug Read More »

Design Sem Nome 1

A New Study Recommends Diabetes Mellitus Drugs Could Slow Alzheimer’s Progression

A brand-new study released in the journal Neurology reports an association between a particular substance class to deal with type 2 diabetes and lowered Alzheimer’s disease biomarkers. It is unclear exactly just how these diabetes mellitus medicines might cause neuroprotective effects, but Alzheimer’s experts are calling for massive clinical trials to explore these possible treatments

A New Study Recommends Diabetes Mellitus Drugs Could Slow Alzheimer’s Progression Read More »

Scroll to Top